Merck Gains Positive EU CHMP Opinion for KEYTRUDA and Padcev
RAHWAY, N.J. — September 18, 2026 Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
antibody-drug conjugate
Advertisement
Takeda Zasocitinib Gets FDA Priority Review for Psoriasis
Osaka, Japan & Cambridge, Massachusetts, U.S., September 14, 2026 Takeda has announced that the U.S. Food and Drug Administration...
AstraZeneca and Daiichi Sankyo’s Enhertu Delivers 14.3-Month PFS in HER2-Mutant NSCLC
Seoul, South Korea, September 14, 2026 AstraZeneca and Daiichi Sankyo announced positive results from the Phase III DESTINY-Lung04 trial,...
Pyxis Oncology Advances MICVO Toward Phase 3 in HNSCC
BOSTON — September 9, 2026 Pyxis Oncology, Inc. announced positive updated data from its ongoing Phase 1 monotherapy study...
Medicus Pharma Advances Precision Oncology Strategy With CD228V
PHILADELPHIA, Pennsylvania — September 8, 2026 Medicus Pharma Ltd. announced a strategic transformation into a precision oncology-led biotechnology company,...
Advertisements
RedHill Divests Talicia to Apotex for $18 Million
Miami, Florida, August 31, 2026 RedHill Biopharma Ltd. announced that it has entered into an agreement to divest Talicia®...
ASHP and APhA Call for Stronger Medication Safety
Bethesda, Maryland, USA August 21, 2026 The American Society of Health-System Pharmacists (ASHP) and the American Pharmacists Association (APhA)...
Allies of Skin Launches Peptint Tripeptide Lip Treatment
Los Angeles, California, USA, August 21, 2026 Allies of Skin has announced the launch of Peptint Tripeptide & Goji...
Akeso Advances AK157D1 B7-H3 ADC Into Phase I
Hong Kong, August 21, 2026 Akeso, Inc. has announced that its investigational B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received...
Henlius and Sandoz Expand Global Strategic Biosimilar Effort
Shanghai, China, August 17, 2026 Shanghai Henlius Biotech, Inc. and Sandoz have entered into a strategic collaboration to expand...
Advertisement
